Skip to main content
. 2010 Jun 1;28(19):3176–3181. doi: 10.1200/JCO.2009.26.7948

Table 2.

Guideline Concordance Quality of Nonmetastatic Colorectal Cancer Care in the Veterans Health Administration

Quality Indicator Cancer Study Population Qualified Study Sample (No. of patients) Yes Results (%)
Preoperative CT scan of abdomen and pelvis prior to definitive surgical resection Stages II and III colorectal cancer 1,729 72.1
Preoperative CEA determination prior to definitive surgical resection Stages II and III colorectal cancer 1,729 82.8
Documented radial margins were free of tumor at the time definitive surgical resection Stages II and III colorectal cancer 1,725* 81.2
Referral to a medical oncologist Stages II and III colorectal cancer 1,729 77.5
Adjuvant FU or capecitabine administered after definitive surgical resection Stage III colorectal cancer 808 73.5
Surveillance colonoscopy within 7 to 18 months after definitive surgical resection for patients with documentation of no preoperative obstructing lesion Stages I, II, and III colorectal cancer with no preoperative obstructing lesion documented 1,259 43.5

Abbreviations: CT, computed tomography; CEA, carcinoembryonic antigen; FU, fluorouracil.

*

Margins question was missing with four patients.

Of the 1.725 patients for whom the abstraction question pertaining to clear margins was answered, 1400 (81.2%) had documentation of clear margins, 207 (12.0%) had medical record indication that margins were not clear, and for 118 (6.8%) abstractors could not ascertain the margin status from the medical record.